
Browsing restrictions can be lifted for a fee.
1.02%
Spectral ai, inc.
-1.10%
Avg of Sector
-0.49%
S&P500
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for Spectral ai, inc. (MDAI) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MDAI's short-term business performance and financial health. For the latest updates on MDAI's earnings releases, visit this page regularly.
According to the latest financial report, Spectral ai, inc. (MDAI) reported an Operating Profit of -2.24M with an Operating Margin of -54.89% this period, representing a decline of 101.89% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, Spectral ai, inc. (MDAI) announced revenue of 4.09M, with a Year-Over-Year growth rate of -46.27%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
As of the end of the reporting period, Spectral ai, inc. (MDAI) had total debt of 10.09M, with a debt ratio of 0.47. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
At the end of the period, Spectral ai, inc. (MDAI) held Total Cash and Cash Equivalents of 15.39M, accounting for 0.72 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, Spectral ai, inc. (MDAI) did not achieve the “three margins increasing” benchmark, with a gross margin of 45.2%%, operating margin of -54.89%%, and net margin of 25.7%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MDAI's profit trajectory and future growth potential.
According to the past four quarterly reports, Spectral ai, inc. (MDAI)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.05. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
Spectral ai, inc. (MDAI)'s Free Cash Flow (FCF) for the period is -2.55M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 644.14% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
The latest valuation data shows Spectral ai, inc. (MDAI) has a Price-To-Earnings (PE) ratio of -6.47 and a Price/Earnings-To-Growth (PEG) ratio of -0.14. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.